These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 26754661)
1. The role of ANGPTL3 in controlling lipoprotein metabolism. Tikka A; Jauhiainen M Endocrine; 2016 May; 52(2):187-93. PubMed ID: 26754661 [TBL] [Abstract][Full Text] [Related]
3. Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3. Pisciotta L; Favari E; Magnolo L; Simonelli S; Adorni MP; Sallo R; Fancello T; Zavaroni I; Ardigò D; Bernini F; Calabresi L; Franceschini G; Tarugi P; Calandra S; Bertolini S Circ Cardiovasc Genet; 2012 Feb; 5(1):42-50. PubMed ID: 22062970 [TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-like 3 regulates hepatocyte proliferation and lipid metabolism in zebrafish. Lee SH; So JH; Kim HT; Choi JH; Lee MS; Choi SY; Kim CH; Kim MJ Biochem Biophys Res Commun; 2014 Apr; 446(4):1237-42. PubMed ID: 24685482 [TBL] [Abstract][Full Text] [Related]
5. Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids. Robciuc MR; Maranghi M; Lahikainen A; Rader D; Bensadoun A; Öörni K; Metso J; Minicocci I; Ciociola E; Ceci F; Montali A; Arca M; Ehnholm C; Jauhiainen M Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1706-13. PubMed ID: 23661675 [TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia. Di Costanzo A; Di Leo E; Noto D; Cefalù AB; Minicocci I; Polito L; D'Erasmo L; Cantisani V; Spina R; Tarugi P; Averna M; Arca M J Clin Lipidol; 2017; 11(5):1234-1242. PubMed ID: 28733173 [TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. Minicocci I; Santini S; Cantisani V; Stitziel N; Kathiresan S; Arroyo JA; Martí G; Pisciotta L; Noto D; Cefalù AB; Maranghi M; Labbadia G; Pigna G; Pannozzo F; Ceci F; Ciociola E; Bertolini S; Calandra S; Tarugi P; Averna M; Arca M J Lipid Res; 2013 Dec; 54(12):3481-90. PubMed ID: 24058201 [TBL] [Abstract][Full Text] [Related]
8. Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism. Minicocci I; Tikka A; Poggiogalle E; Metso J; Montali A; Ceci F; Labbadia G; Fontana M; Di Costanzo A; Maranghi M; Rosano A; Ehnholm C; Donini LM; Jauhiainen M; Arca M J Lipid Res; 2016 Jun; 57(6):1097-107. PubMed ID: 27040449 [TBL] [Abstract][Full Text] [Related]
9. Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasis. Ossoli A; Minicocci I; Turri M; Di Costanzo A; D'Erasmo L; Bini S; Montavoci L; Veglia F; Calabresi L; Arca M Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Mar; 1868(3):159263. PubMed ID: 36521735 [TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia. Tarugi P; Bertolini S; Calandra S J Biomed Res; 2019 Apr; 33(2):73-81. PubMed ID: 29752428 [TBL] [Abstract][Full Text] [Related]
11. Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits. Mehta N; Qamar A; Qu L; Qasim AN; Mehta NN; Reilly MP; Rader DJ Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1057-63. PubMed ID: 24626437 [TBL] [Abstract][Full Text] [Related]
12. ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins. Ruhanen H; Haridas PAN; Minicocci I; Taskinen JH; Palmas F; di Costanzo A; D'Erasmo L; Metso J; Partanen J; Dalli J; Zhou Y; Arca M; Jauhiainen M; Käkelä R; Olkkonen VM Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jul; 1865(7):158679. PubMed ID: 32151767 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutation. Martín-Campos JM; Roig R; Mayoral C; Martinez S; Martí G; Arroyo JA; Julve J; Blanco-Vaca F Clin Chim Acta; 2012 Mar; 413(5-6):552-5. PubMed ID: 22155345 [TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia. Chen PY; Gao WY; Liou JW; Lin CY; Wu MJ; Yen JH Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298929 [TBL] [Abstract][Full Text] [Related]
18. The angiopoietin-like protein 3: a hepatokine with expanding role in metabolism. Arca M; Minicocci I; Maranghi M Curr Opin Lipidol; 2013 Aug; 24(4):313-20. PubMed ID: 23839332 [TBL] [Abstract][Full Text] [Related]
19. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events. Miida T; Hirayama S Curr Opin Lipidol; 2010 Feb; 21(1):70-5. PubMed ID: 19851103 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia. Noto D; Cefalù AB; Valenti V; Fayer F; Pinotti E; Ditta M; Spina R; Vigna G; Yue P; Kathiresan S; Tarugi P; Averna MR Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):805-9. PubMed ID: 22247256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]